The Enterprise Value as of September 2024 (TTM) for ImmunoCellular Therapeutics, Ltd. (IMUC) is 15.63M

According to ImmunoCellular Therapeutics, Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 15.63M. This represents a change of -34.67% compared to the average of 23.93M of the last 4 quarters.

ImmunoCellular Therapeutics, Ltd. (IMUC) Historical Enterprise Value (quarterly & annually)

How has IMUC Enterprise Value performed in the past?

The mean historical Enterprise Value of ImmunoCellular Therapeutics, Ltd. over the last ten years is 29.04M. The current 15.63M Enterprise Value has changed 5.28% with respect to the historical average. Over the past ten years (40 quarters), IMUC's Enterprise Value was at its highest in in the June 2012 quarter at 138.26M. The Enterprise Value was at its lowest in in the December 2016 quarter at -4154042.00.

ImmunoCellular Therapeutics, Ltd. (IMUC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ImmunoCellular Therapeutics, Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ImmunoCellular Therapeutics, Ltd. (IMUC) Average Enterprise Value

How has IMUC Enterprise Value performed in the past?

The current Enterprise Value of ImmunoCellular Therapeutics, Ltd. (IMUC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ImmunoCellular Therapeutics, Ltd. (IMUC) Enterprise Value vs. Peers

How is IMUC’s Enterprise Value compared to its peers?

ImmunoCellular Therapeutics, Ltd.’s Enterprise Value is less than Northwest Biotherapeutics, Inc. (449.63M), less than Catalyst Pharmaceuticals, Inc. (2.05B), greater than Oxford Cannabinoid Technologies Holdings Plc (1.67M), less than Pharming Group N.V. (598.08M), less than Kane Biotech Inc. (18.06M), less than Health Sciences Group, Inc. (0), less than MedMira Inc. (54.93M), less than Longboard Pharmaceuticals, Inc. (0), less than Lumos Pharma, Inc. (1.21B), less than Cellectar Biosciences, Inc. (21.89M), less than Bolt Biotherapeutics, Inc. (35.44M), less than null (37.23M),

Build a custom stock screener for ImmunoCellular Therapeutics, Ltd. (IMUC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmunoCellular Therapeutics, Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmunoCellular Therapeutics, Ltd. (IMUC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmunoCellular Therapeutics, Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.